Patent · US Active

Substituted pyrazolo[1,5-a]pyrimidines for modulating CDK9 activity

US11155560B2 · kind B2 · utility

0Cited by
17References
4Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 29, 2019
Grant dateOct 26, 2021
Priority date—
Expiry dateOct 29, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D487/04
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Inhibitors of CDK9 that are pyrazolo[1,5-a]pyrimidine derivatives and salts thereof, corresponding to formula (I):

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.